Zentalis Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Zentalis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ZNTL.
Zentalis Pharmaceuticals, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on the discovery and advancement of small molecule therapies designed to treat a range of cancers. The company's pipeline features two primary drug candidates: ZN-c3, an inhibitor of the WEE1 protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. ZN-c3 is currently undergoing various...
Can you invest in Zentalis Pharmaceuticals, Inc.?
Yes. Zentalis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ZNTL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zentalis Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.